OSE Immunotherapeutics (France)

OSE Immunotherapeutics (France)

Open Access statistics for OSE Immunotherapeutics (France), France, covering academic research published from 2000 to 2024.

Open Access statistics for OSE Immunotherapeutics (France), France, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

64%


Total
Publications

124


Total Open
Publications

79


Total
Citations

2.3K


Open Access
Percentage

64%


Total
Publications

124


Total Open
Publications

79


Total
Citations

2.3K

Website

download

Breakdown

27% 32% 5% 36%

Publisher Open

27%

Both

32%

Other Platform Open

5%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

42%OA Journal

OA Journal 42%

31

Hybrid 26%

19

No Guarantees 32%

23

Other Platform Open

Domain 82%

37

Institution 42%

19

Other Internet 36%

16

Preprint 9%

4

Public 9%

4

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
37
Europe PMC
Domain
20
CCSD (Centre pour la Communication Scientifique Directe) - HAL - Nantes Université
Other Internet
12
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART
Other Internet
8
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
7
Le Centre pour la Communication Scientifique Directe - HAL - Inserm
Institution
6
University of Cambridge - Apollo
Institution
4
Semantic Scholar
Public
4
Le Centre pour la Communication Scientifique Directe - HAL - CEA - Commissariat à l'Énergie Atomique
Institution
4
Le Centre pour la Communication Scientifique Directe - HAL - Inria
Institution
3
1 / 3

Data updated 13 February 2025

Share

Share

Share